|Day's Range||32.54 - 32.75|
|52 Week Range||25.25 - 36.82|
|PE Ratio (TTM)||22.86|
|Dividend & Yield||1.03 (3.16%)|
|1y Target Est||35.43|
NEW YORK, June 28, 2017-- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Roche Holding AG who purchased shares between March 2, 2017 and June 5, ...
-- New test option will be available globally mid-2017 in the Harmony CE-IVD kit and through the test send-out service from Ariosa Diagnostics Inc. OTCQX: RHHBY) today announced that it has added 22q11.2 deletion testing to the menu of the Harmony® Prenatal Test, a non-invasive prenatal testing service used for assessing the probability of Down syndrome (trisomy 21) and other chromosomal conditions in the fetus.
While the Republican-led Congress continues the push to repeal the Affordable Care Act, we still see challenges in passing any new legislation.